Key regions: Japan, United States, Europe, United Kingdom, Canada
The Hand Sanitizer (Pharmacies) market in G20 has witnessed significant growth in recent years, driven by changing customer preferences and local special circumstances. With the outbreak of the COVID-19 pandemic, the demand for hand sanitizers has surged, leading to a boom in the market. Customer preferences have played a crucial role in shaping the Hand Sanitizer (Pharmacies) market in G20. Consumers are increasingly concerned about personal hygiene and are taking proactive measures to prevent the spread of diseases. Hand sanitizers have become an essential item for individuals, especially when they are on the go and do not have access to soap and water. The convenience and effectiveness of hand sanitizers have made them a preferred choice for many customers. Trends in the market vary across different countries in the G20. In some countries, there has been a surge in the production and availability of hand sanitizers to meet the increased demand. This has led to a wide range of product offerings, including different sizes, fragrances, and formulations. Some countries have also witnessed a rise in the use of natural and organic hand sanitizers, as customers are becoming more conscious about the ingredients used in the products they use. Local special circumstances have also influenced the Hand Sanitizer (Pharmacies) market in G20. Government regulations and guidelines regarding hand hygiene and the use of sanitizers have played a crucial role in shaping the market. Some countries have implemented strict regulations on the production and labeling of hand sanitizers to ensure their safety and efficacy. Additionally, the availability of hand sanitizers in public places, such as schools, offices, and public transportation, has also contributed to the growth of the market. Underlying macroeconomic factors have further fueled the growth of the Hand Sanitizer (Pharmacies) market in G20. The COVID-19 pandemic has led to an increased focus on healthcare and hygiene, which has created a favorable environment for the market. Additionally, the rising disposable income and changing lifestyles of consumers have also contributed to the growth of the market. As more people become aware of the importance of hand hygiene, the demand for hand sanitizers is expected to continue to grow. In conclusion, the Hand Sanitizer (Pharmacies) market in G20 has experienced significant growth due to changing customer preferences, local special circumstances, and underlying macroeconomic factors. The demand for hand sanitizers is expected to remain strong in the coming years as people continue to prioritize personal hygiene and take preventive measures to stay healthy.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
